reference/36428112

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36428112

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	0893-3952
issueIdentifier	12
pageRange	100332-
publicationName	Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
startingPage	100332
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb4f340a1767b2ff28113b9d3c67834b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aa048e23fd0358a0129a26ab8c57f3bb http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_47b82c0b9fd0c53483463fb1eb08a678 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_96f691fe28be6521ea550fed152beddf
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d85076bb377aae5f4a3c203d3d5dbaf0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_541904086dfca890596a69481cfc857d
bibliographicCitation	Gillis A, Zheng-Pywell R, McLeod C, Wang D, Ness JM, Guenter R, Whitt J, Prolla TA, Chen H, Gonzalez ML, Rose B, Lloyd RV, Jaskula-Sztul R, Lin D. Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment. Modern Pathology. 2023 Dec;36(12):100332. doi: 10.1016/j.modpat.2023.100332.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62032171fc60713c6a665e84953ae395 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4481-5549 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c35ac0212aaaa9f74e0e279e9b4c738 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bbde941dcf382c9a0cf6a94fcef847d5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6bbfd230b3f7c88383cb5e4a2be10e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa2a947d760a64d1b8655b33df3ea71d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70bd8b9b0af740ade4d5b211f6450712 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ee71f4fc41283abb078f6d31462e099 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1195f8af82c3fc7b101f9527e07336d8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_beebd18fba3c69a30425595b38aaa8ff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c07ad2399d9412d233fddc1ca9298774 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e216281750b8dfd7241a4d1ecfc42b51 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd544c1afb03146a5792ee335bc2f994 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0600d3b2fc22b05b966dda9687cbe80e
date	202312
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC10843045 https://doi.org/10.1016/j.modpat.2023.100332 https://pubmed.ncbi.nlm.nih.gov/37716507
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6644 https://portal.issn.org/resource/ISSN/0893-3952
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment
discusses	http://id.nlm.nih.gov/mesh/M0021496 http://id.nlm.nih.gov/mesh/M0018635 http://id.nlm.nih.gov/mesh/M0247124
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009375 http://id.nlm.nih.gov/mesh/D013964Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011989 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D013972 http://id.nlm.nih.gov/mesh/D008875

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCNP_001041 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7253 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCNP_001136098 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6752

Total number of triples: 55.